Optimal size threshold for PIRADSv2 category 5 upgrade and its positive predictive value: is it predictive of "very high" likelihood of clinically-significant cancer?


Journal

Clinical radiology
ISSN: 1365-229X
Titre abrégé: Clin Radiol
Pays: England
ID NLM: 1306016

Informations de publication

Date de publication:
28 Oct 2023
Historique:
received: 12 04 2023
revised: 21 08 2023
accepted: 05 10 2023
medline: 10 11 2023
pubmed: 10 11 2023
entrez: 9 11 2023
Statut: aheadofprint

Résumé

To identify the optimal size metric and threshold for Prostate Imaging Reporting and Data System (PIRADS) 5 upgrade, calculate its positive predictive value (PPV) for clinically-significant prostate cancer (csPCA), and determine if it is indicative of a "very high" likelihood of csPCA. One hundred and forty-three PIRADS 4 or 5 lesions were evaluated. Lesion diameters were used to calculate lesion volume (LV). Pearson correlation between maximum lesion diameter (MLD) and LV was calculated. Area under the curve (AUC) for discriminating csPCA (Gleason grade ≥ 3 + 4) was calculated using MLD and LV. Optimal size thresholds (using Youden index) and highly predictive size thresholds were identified for the whole prostate (WP), peripheral zone (PZ), and transitional zone (TZ). There was high correlation between MLD and LV (r=0.77-0.81), with comparable AUCs for MLD and LV in the identification of csPCA in the WP (0.73, 0.72), PZ (0.73, 0.73), and TZ (0.79, 0.75). Optimal MLD thresholds were 1.4, 1.4, and 1.6 cm in the WP, PZ, and TZ respectively, with PPVs of 76%, 81%, and 69%, respectively. An MLD threshold of 2.7 cm would be needed in the WP to achieve a PPV approaching 90%, with sensitivity decreasing to 10%. There is high correlation between MLD and LV with comparable discrimination of csPCA using each. PIRADSv2's 1.5 cm MLD threshold is near the optimal threshold for PIRADS 5 upgrade but has moderate PPV. A much higher threshold would be needed to increase its PPV, with significant sacrifice in sensitivity.

Identifiants

pubmed: 37945438
pii: S0009-9260(23)00455-5
doi: 10.1016/j.crad.2023.10.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Auteurs

V Batheja (V)

George Washington University School of Medicine, Washington, DC, USA.

M Osman (M)

George Washington University School of Medicine, Washington, DC, USA.

M Wynne (M)

George Washington University School of Medicine, Washington, DC, USA.

D Nemirovsky (D)

George Washington University School of Medicine, Washington, DC, USA.

G Morcos (G)

George Washington University School of Medicine, Washington, DC, USA.

J Riess (J)

Department of Radiology, George Washington Medical Faculty Associates, Washington, DC, USA.

B Shin (B)

Department of Radiology, George Washington Medical Faculty Associates, Washington, DC, USA.

M Whalen (M)

Department of Urology, George Washington Medical Faculty Associates, Washington, DC, USA.

S Haji-Momenian (S)

Department of Radiology, George Washington Medical Faculty Associates, Washington, DC, USA. Electronic address: shajimomenian@mfa.gwu.edu.

Classifications MeSH